ADIPOQ and metabolic dysfunction-associated steatotic liver disease: Exceptions to Fig. 1 include Hara et al. (2002) report of significant adiponectin differences between ADIPOQrs1501299 genotypes for obese Japanese whose mean concentrations were low, but not lean Japanese whose mean adiponectin concentrations were higher; and Gupta et al. reported that the ADIPOQrs2241766 polymorphism significantly affected adiponectin in patients with nonalcoholic fatty liver disease but not controls despite the lower mean concentration of the patients (4.8 vs. 7.2 μg/ml) (Gupta et al., 2012).